Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06981234 · ClinicalTrials.gov registry record · Phase 2

Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial

A Phase 2 study of Type 1 Diabetes, sponsored by University of California, San Diego.

Recruiting
Registry status
Phase 2
Development phase
25
Enrollment target
1
Study location

NCT06981234 is a Phase 2 study of Type 1 Diabetes that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 25 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06981234, a Phase 2 study of Type 1 Diabetes, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
Phase 2
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to learn about the effect of the study drug acetazolamide in individuals with Type 1 Diabetes. Specifically, whether acetazolamide provides benefits to the kidneys while minimizing any side effects of the drug. These changes will be measured by laboratory tests that tell us how well the kidneys are functioning.

Conditions Studied

Type 1 Diabetes

Interventions

  • DRUG Placebo
  • DRUG Acetazolamide

Study Locations (1)

California

  • UC San Diego Altman Clinical & Translational Research Institute - La Jolla

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2024-08-14
Est. Completion 2027-06
Phase Phase 2

Sponsor

University of California, San Diego

775 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06981234

The ClinicalTrials.gov registry entry for NCT06981234 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (97% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06981234 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06981234 about?

NCT06981234 is a clinical study titled "Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial". The goal of this study is to learn about the effect of the study drug acetazolamide in individuals with Type 1 Diabetes. Specifically, whether acetazolamide provides benefits to the kidneys while minimizing any side effects of the drug. These changes will be measured by laboratory tests that tell us...

What is the current status of trial NCT06981234?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2024-08-14. Estimated completion is 2027-06.

What conditions does trial NCT06981234 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT06981234?

The interventions under investigation include: Placebo (DRUG), Acetazolamide (DRUG).

Who is sponsoring clinical trial NCT06981234?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06981234 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 1 Diabetes

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.